This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
influenza virus | 267 |
saudi arabia | 247 |
respiratory syndrome | 217 |
influenza viruses | 159 |
immune response | 147 |
acute respiratory | 138 |
syndrome coronavirus | 136 |
disease virus | 133 |
streptococcus suis | 130 |
virus infection | 129 |
type i | 129 |
infectious bronchitis | 124 |
novel coronavirus | 122 |
severe acute | 122 |
innate immune | 116 |
swine influenza | 115 |
united states | 95 |
pdm virus | 92 |
mouth disease | 92 |
bronchitis virus | 92 |
avian influenza | 91 |
middle east | 88 |
public health | 86 |
spike protein | 83 |
fever virus | 81 |
gene expression | 81 |
swine fever | 80 |
infectious peritonitis | 78 |
east respiratory | 78 |
classical swine | 78 |
feline infectious | 77 |
epithelial cells | 76 |
immune responses | 76 |
viral rna | 73 |
fecal samples | 71 |
host cell | 69 |
infected cells | 65 |
amino acid | 65 |
wild birds | 63 |
feline coronavirus | 62 |
respiratory tract | 61 |
viral replication | 58 |
highly pathogenic | 58 |
immune cells | 55 |
virus replication | 55 |
innate immunity | 55 |
rift valley | 54 |
host cells | 54 |
valley fever | 52 |
immune system | 51 |
toxoplasma gondii | 50 |
fcov zu | 50 |
diarrhea virus | 49 |
suis serotype | 48 |
respiratory disease | 47 |
coronavirus infection | 47 |
porcine epidemic | 46 |
sars coronavirus | 45 |
samples collected | 44 |
day post | 44 |
infected animals | 43 |
viral infection | 43 |
coronavirus disease | 43 |
i ifn | 42 |
rna viruses | 42 |
virus isolates | 42 |
clinical signs | 42 |
epidemic diarrhea | 41 |
antibody titers | 41 |
cell surface | 41 |
risk factors | 41 |
pathogens doi | 40 |
doc id | 40 |
pedv nsp | 40 |
pathogens sha | 40 |
cord uid | 40 |
sialic acid | 39 |
cov infection | 39 |
class i | 39 |
west nile | 38 |
pdz proteins | 38 |
iav infection | 37 |
infectious diseases | 37 |
swine farm | 37 |
signaling pathway | 36 |
converting enzyme | 36 |
present study | 35 |
animals infected | 35 |
coronavirus spike | 35 |
mycobacterium avium | 35 |
shed fcov | 34 |
virus transmission | 34 |
swine samples | 34 |
newcastle disease | 34 |
hemorrhagic fever | 34 |
viral proteins | 33 |
north america | 33 |
closely related | 33 |
fecal virus | 33 |
nasal swabs | 33 |
antibody titer | 32 |
ursolic acid | 32 |
i interferon | 32 |
autogenous vaccines | 32 |
virus infections | 32 |
human papillomavirus | 31 |
genetic diversity | 31 |
another study | 31 |
zoonotic diseases | 31 |
type ii | 31 |
phylogenetic analysis | 31 |
nasal swab | 30 |
genetic characterization | 30 |
pdz domain | 30 |
drinking water | 30 |
infectious salmon | 30 |
receptor binding | 30 |
world health | 30 |
pdz protein | 30 |
viral infections | 29 |
organ systems | 29 |
time rt | 29 |
nile virus | 29 |
health organization | 29 |
iav strains | 29 |
type iii | 29 |
escherichia coli | 29 |
chain reaction | 28 |
phage therapy | 28 |
wild boars | 28 |
neutralizing antibodies | 28 |
cell lines | 28 |
time pcr | 28 |
virus isolation | 28 |
polymerase chain | 28 |
endothelial cells | 28 |
binding domain | 28 |
host innate | 27 |
viral genome | 27 |
pdm none | 27 |
antimicrobial resistance | 27 |
large intestine | 27 |
bovine viral | 27 |
swine farms | 27 |
four fecal | 27 |
authors declare | 27 |
important role | 26 |
pdm viruses | 26 |
membrane fusion | 26 |
systematic review | 26 |
fusion protein | 26 |
recent study | 26 |
infected cats | 26 |
fip group | 26 |
non fip | 26 |
avian infectious | 26 |
previous studies | 26 |
chinese swine | 25 |
cell culture | 25 |
transcription factors | 25 |
protein expression | 25 |
endothelial cell | 25 |
host immune | 25 |
human transmission | 25 |
organ system | 25 |
complete genome | 25 |
protein kinase | 25 |
ifn production | 25 |
cleavage site | 25 |
fip cats | 25 |
significantly higher | 25 |
reverse transcription | 25 |
binding affinity | 25 |
pandemic influenza | 24 |
feral swine | 24 |
may also | 24 |
cells treated | 24 |
severe covid | 24 |
viral diseases | 24 |
transcription factor | 24 |
suis strains | 24 |
fusion activity | 24 |
virus shedding | 24 |
single nucleotide | 23 |
first report | 23 |
least one | 23 |
iav positive | 23 |
target cells | 23 |
virus isolated | 23 |
syndrome virus | 23 |
serum samples | 23 |
binding motif | 23 |
upper respiratory | 23 |
like receptor | 23 |
previously described | 23 |
reverse transcriptase | 23 |
viral load | 23 |
like protease | 23 |
thermo fisher | 23 |
preventive measures | 23 |
monoclonal antibody | 22 |
cell infection | 22 |
shedding fcov | 22 |
nonstructural protein | 22 |
fusion mechanism | 22 |
adaptive immune | 22 |
virus strains | 22 |
histological lesions | 22 |
internal organ | 22 |
virus host | 22 |
amino acids | 22 |
host protein | 22 |
crucial role | 22 |
porcine reproductive | 22 |
dependent manner | 22 |
dna methylation | 22 |
avium subsp | 22 |
virus type | 22 |
swine sera | 21 |
nucleocapsid protein | 21 |
mean fecal | 21 |
challenge stock | 21 |
experimental infection | 21 |
swine populations | 21 |
zoonotic disease | 21 |
buffalopox virus | 21 |
pcr assay | 21 |
respiratory illness | 21 |
supplementary table | 21 |
viral entry | 21 |
human health | 21 |
incubation period | 20 |
human influenza | 20 |
structural proteins | 20 |
rna polymerase | 20 |
cats shedding | 20 |
virus genome | 20 |
infectious disease | 20 |
risk assessment | 20 |
vaccinia virus | 20 |
cell line | 20 |
dendritic cells | 20 |
suis infection | 20 |
ibv strains | 20 |
host range | 20 |
american orthohantaviruses | 20 |
tight junction | 20 |
cell epitopes | 20 |
pathogenic avian | 20 |
life cycle | 20 |
virus antibodies | 20 |
feline coronaviruses | 20 |
immunodeficiency virus | 20 |
nucleotide polymorphisms | 19 |
serotype st | 19 |
experimentally infected | 19 |
signaling pathways | 19 |
antiviral response | 19 |
infected patients | 19 |
monoclonal antibodies | 19 |
human infections | 19 |
retinoic acid | 19 |
creative commons | 19 |
nucleic acid | 19 |
regulatory factor | 19 |
post infection | 19 |
several studies | 19 |
second survey | 19 |
rna synthesis | 19 |
i mhc | 19 |
human infection | 19 |
swine appeared | 19 |
open access | 18 |
fatality rate | 18 |
apparently healthy | 18 |
diarrhoea virus | 18 |
small intestine | 18 |
suis isolates | 18 |
zoonotic pathogens | 18 |
host response | 18 |
ace receptor | 18 |
naturally infected | 18 |
lymph node | 18 |
like symptoms | 18 |
zoonotic potential | 18 |
active infection | 18 |
live attenuated | 18 |
hepatitis virus | 18 |
positive results | 18 |
zoonotic transmission | 18 |
peritonitis virus | 18 |
cell responses | 18 |
genome sequence | 18 |
nuclear translocation | 18 |
large number | 18 |
mortality rate | 18 |
patients infected | 18 |
internal organs | 18 |
transmission modes | 17 |
viral protein | 17 |
article distributed | 17 |
clinical disease | 17 |
immunogenic proteins | 17 |
ns protein | 17 |
influenza infection | 17 |
rapid detection | 17 |
access article | 17 |
cov infections | 17 |
human immunodeficiency | 17 |
vaccine development | 17 |
domestic birds | 17 |
clinical characteristics | 17 |
zoonotic viral | 17 |
positive swine | 17 |
host antiviral | 17 |
hong kong | 17 |
analysis based | 17 |
rna virus | 17 |
peer review | 17 |
sera samples | 17 |
performed using | 17 |
cov nsp | 17 |
spike proteins | 17 |
serotype isolates | 17 |
binding protein | 17 |
tissue fecal | 17 |
migratory birds | 17 |
clinical cases | 17 |
serological evidence | 17 |
ifn signaling | 17 |
ask cells | 17 |
clinical isolates | 17 |
infected group | 17 |
rabies virus | 17 |
confirmed cases | 17 |
commons attribution | 17 |
viral sequences | 17 |
inhibitory effect | 17 |
human coronavirus | 16 |
antibody responses | 16 |
host interactions | 16 |
iii ifn | 16 |
disease outbreak | 16 |
host gene | 16 |
also reported | 16 |
transmission dynamics | 16 |
stock virus | 16 |
secondary bacterial | 16 |
animal models | 16 |
viruses isolated | 16 |
generation sequencing | 16 |
virus infiltration | 16 |
structural protein | 16 |
host tropism | 16 |
anemia virus | 16 |
gene i | 16 |
virus environmental | 16 |
stranded rna | 16 |
significantly increased | 16 |
disease severity | 16 |
virus load | 16 |
found positive | 16 |
fmdv protein | 16 |
highly conserved | 16 |
environmental survival | 16 |
pulmonary syndrome | 16 |
global health | 16 |
histone modification | 16 |
molecular characterization | 16 |
inducible gene | 16 |
serotype strains | 16 |
inflammatory cytokines | 16 |
virus entry | 16 |
clinical features | 16 |
nonstructural proteins | 16 |
cell entry | 16 |
waterborne pathogens | 15 |
dromedary camels | 15 |
immune evasion | 15 |
viral particle | 15 |
available online | 15 |
gondii infection | 15 |
viral diarrhea | 15 |
previous study | 15 |
neutralizing antibody | 15 |
origin iav | 15 |
cell cycle | 15 |
human ace | 15 |
virus disease | 15 |
new coronavirus | 15 |
salmon anemia | 15 |
mexican swine | 15 |
body infiltration | 15 |
clinical symptoms | 15 |
virus strain | 15 |
suis infections | 15 |
zoonotic infections | 15 |
specific antibodies | 15 |
inflammatory response | 15 |
mouse hepatitis | 15 |
protein sequences | 15 |
seasonal influenza | 15 |
infected pigs | 15 |
higher antibody | 15 |
cell membrane | 15 |
bacterial pathogens | 15 |
healthy cats | 15 |
recent years | 15 |
highly virulent | 15 |
serine protease | 15 |
salmon anaemia | 15 |
lesions consistent | 15 |
swine transmission | 15 |
host responses | 15 |
ibv infection | 15 |
infection period | 15 |
viral loads | 14 |
nuclear factor | 14 |
like receptors | 14 |
fmdv infection | 14 |
genome sequencing | 14 |
plasma membrane | 14 |
survival rate | 14 |
expression levels | 14 |
close contact | 14 |
human genome | 14 |
antiviral responses | 14 |
like illness | 14 |
tight junctions | 14 |
hantavirus pulmonary | 14 |
vp protein | 14 |
nile delta | 14 |
internal genes | 14 |
associated factor | 14 |
cell receptor | 14 |
atlantic salmon | 14 |
study reported | 14 |
highest number | 14 |
case fatality | 14 |
european countries | 14 |
positive samples | 14 |
carriage isolates | 14 |
zoonotic infection | 14 |
systems biology | 14 |
epitope prediction | 14 |
swine population | 14 |
cytokine receptor | 14 |
borne zoonotic | 14 |
histone marks | 14 |
epidemiological data | 14 |
swine herds | 14 |
influenza pandemic | 14 |
spike glycoprotein | 14 |
molecular epidemiology | 14 |
virus evolution | 14 |
two different | 14 |
papillomavirus type | 14 |
viral pathogens | 14 |
treated groups | 14 |
human cases | 13 |
microarray analysis | 13 |
viral diarrhoea | 13 |
many countries | 13 |
days post | 13 |
viruses belonging | 13 |
porcine respiratory | 13 |
ebola virus | 13 |
clinical manifestations | 13 |
risk factor | 13 |
antiviral innate | 13 |
four virus | 13 |
health concern | 13 |
cattle infected | 13 |
fisher scientific | 13 |
leukemia virus | 13 |
ibv strain | 13 |
zoonotic dis | 13 |
dependent enhancement | 13 |
tested positive | 13 |
effective vaccine | 13 |
study identified | 13 |
highly contagious | 13 |
interferon regulatory | 13 |
fusion peptide | 13 |
clinical trials | 13 |
animal species | 13 |
peripheral blood | 13 |
secondary structure | 13 |
found infected | 13 |
endoplasmic reticulum | 13 |
cytokine storm | 13 |
immune signaling | 13 |
two decades | 13 |
sars patients | 13 |
taken together | 13 |
antibody response | 13 |
pdz binding | 13 |
species transmission | 13 |
arabian peninsula | 13 |
wide range | 13 |
signal transduction | 13 |
negatively regulates | 13 |
histone modifications | 13 |
cats without | 13 |
open reading | 13 |
respiratory distress | 13 |
stop codon | 13 |
high risk | 13 |
congo hemorrhagic | 12 |
current study | 12 |
virulence genes | 12 |
high prevalence | 12 |
strain ns | 12 |
diseased pigs | 12 |
regulatory elements | 12 |
epigenetic modifications | 12 |
specific antibody | 12 |
molecular mechanisms | 12 |
case report | 12 |
humoral immune | 12 |
commonly used | 12 |
complete genomes | 12 |
infected swine | 12 |
interspecies transmission | 12 |
sialic acids | 12 |
avium subspecies | 12 |
anaemia virus | 12 |
virulence factors | 12 |
weight loss | 12 |
linked immunosorbent | 12 |
bat origin | 12 |
three rt | 12 |
feline enteric | 12 |
fcov shedding | 12 |
increased risk | 12 |
early stage | 12 |
functional receptor | 12 |
iii ifns | 12 |
infections among | 12 |
mouse model | 12 |
situ hybridization | 12 |
based swine | 12 |
severe respiratory | 12 |
cell death | 12 |
acid change | 12 |
immune escape | 12 |
suis disease | 12 |
terminal domain | 12 |
different concentrations | 12 |
whole genome | 12 |
weak positive | 12 |
study showed | 12 |
peptide sequences | 12 |
isothermal amplification | 12 |
tissue samples | 12 |
animal health | 12 |
immune cell | 12 |
avian species | 12 |
mediated isothermal | 12 |
different localities | 12 |
respiratory viruses | 12 |
infection severity | 12 |
tnf receptor | 12 |
epithelial cell | 12 |
proinflammatory cytokines | 12 |
swine nasal | 11 |
sequence alignment | 11 |
enzymatic activity | 11 |
positive rt | 11 |
infected individuals | 11 |
information regarding | 11 |
time points | 11 |
airway epithelial | 11 |
south america | 11 |
esterase activity | 11 |
infected immune | 11 |
iav infections | 11 |
beta strands | 11 |
direct contact | 11 |
strain ao | 11 |
widely used | 11 |
cell leukemia | 11 |
iav subtypes | 11 |
na genes | 11 |
enteric coronavirus | 11 |
recognition receptors | 11 |
high similarity | 11 |
strains isolated | 11 |
significant differences | 11 |
expression patterns | 11 |
structural basis | 11 |
mutation frequencies | 11 |
quantitative pcr | 11 |
ibv replication | 11 |
data sets | 11 |
causative agent | 11 |
japanese swine | 11 |
mediated antiviral | 11 |
vaccination strategies | 11 |
infected groups | 11 |
sequence identity | 11 |
simultaneous detection | 11 |
past exposure | 11 |
fmdv vp | 11 |
subspecies paratuberculosis | 11 |
antiviral immunity | 11 |
wild bird | 11 |
specific igg | 11 |
viral particles | 11 |
host factors | 11 |
mesenteric lymph | 11 |
south korea | 11 |
farm workers | 11 |
severe disease | 11 |
viruses reported | 11 |
sense rna | 11 |
also known | 11 |
coronavirus nsp | 11 |
chicken parvovirus | 11 |
asian countries | 11 |
promote virus | 11 |
map infection | 11 |
promoter region | 11 |
authors found | 11 |
first detected | 11 |
healthy swine | 11 |
fcov infection | 11 |
hypothetical protein | 11 |
detection methods | 11 |
tumor necrosis | 11 |
discs large | 11 |
human coronaviruses | 11 |
disease symptoms | 11 |
dengue fever | 11 |
systemic spread | 11 |
sin nombre | 11 |
body fashion | 11 |
immunofluorescence assays | 10 |
lung tissues | 10 |
gene mutations | 10 |
even though | 10 |
data suggest | 10 |
general population | 10 |
water distribution | 10 |
water quality | 10 |
recent advances | 10 |
viral pneumonia | 10 |
positive fecal | 10 |
million people | 10 |
iav antibodies | 10 |
viral envelope | 10 |
class ii | 10 |
camostat mesylate | 10 |
swine production | 10 |
convalescent plasma | 10 |
better understanding | 10 |
subcellular organelles | 10 |
distress syndrome | 10 |
face masks | 10 |
human monoclonal | 10 |
genome sequences | 10 |
different strains | 10 |
genetic analysis | 10 |
chromatin remodeling | 10 |
human population | 10 |
fusion process | 10 |
fcov antibody | 10 |
neighboring countries | 10 |
statistically significant | 10 |
pcr based | 10 |
protein sequence | 10 |
inflammatory cytokine | 10 |
host proteins | 10 |
tumour suppressor | 10 |
different species | 10 |
cell types | 10 |
ua compared | 10 |
become infected | 10 |
viral disease | 10 |
body environment | 10 |
cells infected | 10 |
isav hpr | 10 |
molecular methods | 10 |
immunoreactive proteins | 10 |
blood samples | 10 |
may lead | 10 |
infection compared | 10 |
international committee | 10 |
cell growth | 10 |
also documented | 10 |
microbial risk | 10 |
st isolates | 10 |
results indicate | 10 |
family coronaviridae | 10 |
lung injury | 10 |
two cats | 10 |
influenza vaccine | 10 |
alveolar macrophages | 10 |
human airway | 10 |
like disease | 10 |
ib vaccination | 10 |
viruses circulating | 10 |
pathogenic strains | 10 |
clinical trial | 10 |
necrosis factor | 10 |
bordetella bronchiseptica | 10 |
infection among | 10 |
sequence analysis | 10 |
recent studies | 10 |
virus rna | 10 |
pathogenic viruses | 10 |
may play | 10 |
health risk | 10 |
systemic infection | 10 |
interferon production | 10 |
enteric viruses | 10 |
invasive disease | 10 |
severity level | 10 |
ifn response | 10 |
strain pi | 10 |
immunosorbent assay | 10 |
lung epithelial | 10 |
acid sequence | 10 |
envelope protein | 10 |
vector vaccines | 10 |
reproductive tract | 10 |
acid changes | 10 |
virus families | 10 |
also found | 10 |
foreign gene | 10 |
tax pbm | 10 |
omics data | 10 |
one study | 10 |
growth factor | 9 |
infiltration score | 9 |
inner membrane | 9 |
replication cycle | 9 |
basophil cells | 9 |
southern china | 9 |
crystal structure | 9 |
several countries | 9 |
seven days | 9 |
mass spectrometry | 9 |
last two | 9 |
active iav | 9 |
step rt | 9 |
farm animals | 9 |
cryptosporidium spp | 9 |
pcr assays | 9 |
molecular techniques | 9 |
serotype ii | 9 |
infected chickens | 9 |
consensus sequences | 9 |
infection cycle | 9 |
disease control | 9 |
first time | 9 |
hcps cases | 9 |
last years | 9 |
novel reassortant | 9 |
considered positive | 9 |
intracellular organelles | 9 |
accession number | 9 |
field strains | 9 |
countries including | 9 |
coronavirus pneumonia | 9 |
attenuated vaccines | 9 |
australian swine | 9 |
junction protein | 9 |
er stress | 9 |
emerging pathogens | 9 |
specific pathogen | 9 |
gene segments | 9 |
strain replacement | 9 |
higher mean | 9 |
intermediate hosts | 9 |
low pathogenic | 9 |
rodent hosts | 9 |
vaccinated animals | 9 |
persistently infected | 9 |
nucleotide sequences | 9 |
dependent rna | 9 |
flu pandemic | 9 |
inflammatory responses | 9 |
rodent species | 9 |
fmdv replication | 9 |
challenge virus | 9 |
may occur | 9 |
potentially consistent | 9 |
st strains | 9 |
swine industry | 9 |
factors associated | 9 |
rna genome | 9 |
study found | 9 |
negative results | 9 |
tumor suppressor | 9 |
human cells | 9 |
virus organ | 9 |
dna microarray | 9 |
reverse genetics | 9 |
rna family | 9 |
virus may | 9 |
northern shoveler | 9 |
available data | 9 |
last decade | 9 |
infected pneumonia | 9 |
among pigs | 9 |
future studies | 9 |
pedv infection | 9 |
thai swine | 9 |
bacterial infections | 9 |
adherence scores | 9 |
transcriptase pcr | 9 |
ros production | 9 |
phages may | 9 |
increasing number | 9 |
salmo salar | 9 |
calu cells | 9 |
heat shock | 9 |
full genome | 9 |
emerging zoonotic | 9 |
serological surveillance | 9 |
three times | 9 |
membrane complex | 9 |
laboratory diagnosis | 9 |
constructed using | 9 |
diagnostic tools | 9 |
accessory protein | 9 |
zoonotic pathogen | 9 |
endothelial infection | 9 |
descriptive study | 9 |
nsp inhibits | 9 |
listeria monocytogenes | 9 |
antiviral drugs | 9 |
phylogenetic trees | 9 |
first case | 9 |
chromatin structure | 9 |
influenza disease | 9 |
swab samples | 9 |
early phase | 9 |
tissue culture | 9 |
new virus | 9 |
fecal sample | 9 |
north american | 9 |
inhibits type | 9 |
quantitative microbial | 9 |
among swine | 8 |
strand rna | 8 |
less virulent | 8 |
pathological findings | 8 |
vaccine strains | 8 |
vaccine effectiveness | 8 |
epithelial modes | 8 |
pdz domains | 8 |
intestinal epithelial | 8 |
virus among | 8 |
epitope sequences | 8 |
cell proliferation | 8 |
limited number | 8 |
mock group | 8 |
binding site | 8 |
duodenal loop | 8 |
egyptian children | 8 |
united kingdom | 8 |
oral fluid | 8 |
cell tropism | 8 |
production systems | 8 |
virus loads | 8 |
associated coronavirus | 8 |
suis serotypes | 8 |
potential role | 8 |
hospitalized patients | 8 |
gene bodies | 8 |
zu strain | 8 |
emerging coronavirus | 8 |
low prevalence | 8 |
cohort study | 8 |
swine clinical | 8 |
different serotypes | 8 |
sequences encoding | 8 |
rna replication | 8 |
cell transformation | 8 |
persistent infections | 8 |
homologous recombination | 8 |
human lung | 8 |
high mortality | 8 |
one amino | 8 |
fcov rna | 8 |
human cov | 8 |
diagnostic methods | 8 |
recent decades | 8 |
signalling pathways | 8 |
humoral response | 8 |
virus infected | 8 |
viral vector | 8 |
viral zoonotic | 8 |
viral gene | 8 |
positive ihc | 8 |
pandemic potential | 8 |
significantly lower | 8 |
abattoir workers | 8 |
phylogenetic analyses | 8 |
consensus sequence | 8 |
start codon | 8 |
negative rt | 8 |
climate change | 8 |
first described | 8 |
serious public | 8 |
differentially expressed | 8 |
initiation factor | 8 |
poultry industry | 8 |
previously published | 8 |
lung tissue | 8 |
wild type | 8 |
mhc haplotypes | 8 |
pattern recognition | 8 |
containing proteins | 8 |
reassortant influenza | 8 |
i fcovs | 8 |
diagnostic tests | 8 |
authors also | 8 |
new york | 8 |
without antibodies | 8 |
polymicrobial infections | 8 |
iiv il | 8 |
alimentary tract | 8 |
different time | 8 |
protein interacts | 8 |
complement system | 8 |
cancer cells | 8 |
disease progression | 8 |
binding oligomerization | 8 |
dub activity | 8 |
resistant bacteria | 8 |
mediterranean region | 8 |
accessory genes | 8 |
years old | 8 |
gel electrophoresis | 8 |
disease outbreaks | 8 |
different organs | 8 |
ang ii | 8 |
healthy carrier | 8 |
protein vp | 8 |
reading frame | 8 |
viable cells | 8 |
antibody production | 8 |
may result | 8 |
type ifns | 8 |
current knowledge | 8 |
receptor gene | 8 |
vaccine vector | 8 |
high seroprevalence | 8 |
low sensitivity | 8 |
high throughput | 8 |
plant expression | 8 |
protease tmprss | 8 |
signal pathway | 8 |
qpcr results | 8 |
genomic characterization | 8 |
results demonstrate | 8 |
monocytes macrophages | 8 |
four samples | 8 |
suis virulence | 8 |
coronavirus replication | 8 |
first reported | 8 |
swabs collected | 8 |
oligomerization domain | 8 |
cellular immune | 8 |
economic losses | 8 |
lymph nodes | 8 |
african swine | 8 |
virus vaccine | 8 |
transmission ecology | 8 |
capsid protein | 8 |
body systems | 8 |
time point | 8 |
sequence typing | 8 |
also showed | 8 |
first survey | 8 |
potential therapeutic | 8 |
interleukin receptor | 8 |
european swine | 8 |
equine viruses | 8 |
vp gene | 8 |
cultured immune | 8 |
sequence homology | 8 |
core protein | 8 |
mediated immune | 8 |
positive cats | 8 |
human primates | 8 |
dengue virus | 8 |
nombre virus | 8 |
drug resistance | 8 |
abc genes | 8 |
host genes | 8 |
stunting syndrome | 8 |
cell polarity | 8 |
intermediate host | 8 |
protein nsp | 8 |
reproduction number | 8 |
chest ct | 8 |
old world | 8 |
severe influenza | 8 |
domestic animals | 8 |
related coronavirus | 8 |
effective vaccines | 8 |
cell receptors | 8 |
clinical presentation | 8 |
antigenic characterization | 8 |
bat coronaviruses | 7 |
binding kinase | 7 |
negative ihc | 7 |
vitro studies | 7 |
virus life | 7 |
snp rs | 7 |
another report | 7 |
specific detection | 7 |
putative virulence | 7 |
control measures | 7 |
ion channel | 7 |
dna immunoprecipitation | 7 |
well plate | 7 |
infection model | 7 |
corona virus | 7 |
social media | 7 |
virus circulation | 7 |
bronchitis coronavirus | 7 |
tissue tropism | 7 |
publicly available | 7 |
recombinant vaccinia | 7 |
pregnant women | 7 |
recombinant proteins | 7 |
animal interface | 7 |
suspected cases | 7 |
cell response | 7 |
virus nsp | 7 |
future perspectives | 7 |
em structure | 7 |
multilocus sequence | 7 |
african region | 7 |
candidate epitopes | 7 |
vice versa | 7 |
perinatal antimicrobials | 7 |
severe cases | 7 |
epitopes prediction | 7 |
diagnostic purposes | 7 |
positive result | 7 |
world orthohantaviruses | 7 |
multiple species | 7 |
still unknown | 7 |
critical roles | 7 |
pneumonia outbreak | 7 |
coxiella burnetii | 7 |
porcine circovirus | 7 |
dhf infection | 7 |
one human | 7 |
human fascioliasis | 7 |
one weak | 7 |
protein synthesis | 7 |
cov outbreak | 7 |
tissue distribution | 7 |
translation initiation | 7 |
cryptosporidium parvum | 7 |
epigenetic regulation | 7 |
system involvement | 7 |
antibody elisa | 7 |
serotype strain | 7 |
mucosal immune | 7 |
receptor recognition | 7 |
virulent strains | 7 |
first evidence | 7 |
hai titers | 7 |
age groups | 7 |
different animal | 7 |
complete vp | 7 |
health emergency | 7 |
basic reproduction | 7 |
equine influenza | 7 |
family ranking | 7 |
live bird | 7 |
analyzed using | 7 |
one day | 7 |
likely due | 7 |
human respiratory | 7 |
mhc molecules | 7 |
virus establishment | 7 |
adherence score | 7 |
poultry workers | 7 |
ifn antagonist | 7 |
health education | 7 |
vaccine efficacy | 7 |
serological investigation | 7 |
alkhurma hemorrhagic | 7 |
causes severe | 7 |
yeast two | 7 |
congo haemorrhagic | 7 |
broiler chickens | 7 |
transiently infected | 7 |
antiviral immune | 7 |
protein gene | 7 |
associated risk | 7 |
nasal microbiota | 7 |
respiratory epithelium | 7 |
avian coronavirus | 7 |
including saudi | 7 |
three days | 7 |
infiltration scores | 7 |
virus nonstructural | 7 |
dipeptidyl peptidase | 7 |
previously reported | 7 |
cell apoptosis | 7 |
ib vaccines | 7 |
severe coronavirus | 7 |
system tropism | 7 |
viral hemagglutinins | 7 |
determine whether | 7 |
accessory proteins | 7 |
also detected | 7 |
core genome | 7 |
like particles | 7 |
i ifns | 7 |
respiratory symptoms | 7 |
mhc epitopes | 7 |
mrna expression | 7 |
gastrointestinal tract | 7 |
origin influenza | 7 |
severe clinical | 7 |
associated proteins | 7 |
health care | 7 |
virulence factor | 7 |
respiratory coronavirus | 7 |
retrospective study | 7 |
critical role | 7 |
cause disease | 7 |
epidemiological link | 7 |
diagnostic test | 7 |
total rna | 7 |
hubei province | 7 |
human viruses | 7 |
transcription pcr | 7 |
serological survey | 7 |
selected proteins | 7 |
cov spike | 7 |
csfv infection | 7 |
also shown | 7 |
risk human | 7 |
pathogenic coronaviruses | 7 |
stat signaling | 7 |
findings suggest | 7 |
blocking buffer | 7 |
bacterial infection | 7 |
autogenous vaccine | 7 |
high mutation | 7 |
quantitative real | 7 |
genomic rna | 7 |
egg production | 7 |
rna recognition | 7 |
backyard swine | 7 |
qpcr assay | 7 |
mers coronavirus | 7 |
alphaiib beta | 7 |
maternal antibodies | 7 |
virulent fcovs | 7 |
saudi arabian | 7 |
disease pathogenesis | 7 |
cellular receptor | 7 |
urgent need | 7 |
coronavirus associated | 7 |
antiviral effect | 7 |
new viral | 7 |
histological examination | 7 |
septic shock | 7 |
food safety | 7 |
natural infection | 7 |
may contribute | 7 |
washed twice | 7 |
first step | 7 |
surface proteins | 7 |
studies reported | 7 |
less severe | 7 |
commercially available | 7 |
control strategies | 7 |
avian coronaviruses | 7 |
respiratory diseases | 7 |
acid residues | 7 |
human isolates | 7 |
epigenetic control | 7 |
host transcription | 7 |
wet market | 7 |
systemic immunity | 7 |
infection outcomes | 7 |
direct interaction | 7 |
lesser extent | 7 |
nucleic acids | 7 |
positive control | 7 |
new cases | 7 |
methylated dna | 7 |
carrier cats | 7 |
among different | 7 |
may facilitate | 7 |
type tax | 7 |
agarose gel | 7 |
ii fcovs | 7 |
days prior | 7 |
eastern mediterranean | 7 |
thereby inhibiting | 7 |
antiviral activities | 7 |
transcription polymerase | 7 |
italian swine | 7 |
novel influenza | 7 |
one health | 7 |
histone tails | 7 |
coronavirus nucleocapsid | 7 |
structural studies | 7 |
hepatocellular carcinoma | 7 |
transcription start | 7 |
switching events | 7 |
viral genomes | 7 |
korean swine | 7 |
critically important | 7 |
swine lung | 7 |
fecal fcov | 7 |
orthomyxoviridae family | 7 |
epidemiological studies | 7 |
transcriptase polymerase | 7 |
host environment | 7 |
differential expression | 7 |
ace expression | 7 |
giardia duodenalis | 7 |
shock protein | 7 |
pedv plp | 7 |
haemorrhagic fever | 7 |
untranslated region | 7 |
supplementary materials | 7 |
infecting ibv | 7 |
genomic dna | 7 |
binding lectin | 7 |
epigenetic landscape | 7 |
molecular detection | 7 |
molecular mechanism | 6 |
replacement evolution | 6 |
infected macrophages | 6 |
cell invasion | 6 |
scores allocated | 6 |
commercial swine | 6 |
neutralization test | 6 |
antibody detection | 6 |
human workers | 6 |
antigenic drift | 6 |
differences per | 6 |
etiological agent | 6 |
better understand | 6 |
four cats | 6 |
data regarding | 6 |
cellular receptors | 6 |
developing countries | 6 |
influenza surveillance | 6 |
stimulated genes | 6 |
suis isolated | 6 |
significantly reduced | 6 |
early diagnosis | 6 |
coronavirus receptor | 6 |
st clones | 6 |
respiratory pathogens | 6 |
disease caused | 6 |
saudi nationals | 6 |
selective pressure | 6 |
key step | 6 |
higher mortality | 6 |
parasitic infection | 6 |
may become | 6 |
swine herd | 6 |
nsp protein | 6 |
pedv orf | 6 |
virus family | 6 |
comprehensive review | 6 |
coronavirus papain | 6 |
universal vaccine | 6 |
drosophila discs | 6 |
foreign genes | 6 |
nucleotide polymorphism | 6 |
virus variants | 6 |
family member | 6 |
virus types | 6 |
large amounts | 6 |
virus reassortment | 6 |
subclinical infection | 6 |
rural areas | 6 |
experimental groups | 6 |
positive cases | 6 |
lower respiratory | 6 |
envelope glycoprotein | 6 |
highest rate | 6 |
leader proteinase | 6 |
human rabies | 6 |
mucosal infection | 6 |
subunit vaccine | 6 |
cells expressing | 6 |
like proteases | 6 |
zoonotic viruses | 6 |
suis type | 6 |
protein map | 6 |
sequencing approach | 6 |
south africa | 6 |
group treated | 6 |
vp sequences | 6 |
cell function | 6 |
orf abc | 6 |
iav strain | 6 |
less likely | 6 |
livestock trade | 6 |
fetal bovine | 6 |
coronavirus infectious | 6 |
reported earlier | 6 |
plaque assay | 6 |
dairy cattle | 6 |
virus orf | 6 |
study suggested | 6 |
time reverse | 6 |
differential diagnosis | 6 |
like viruses | 6 |
mild disease | 6 |
epidemiological characteristics | 6 |
induced ifn | 6 |
nephropathogenic ibv | 6 |
strain isolated | 6 |
coding region | 6 |
bronchitis viruses | 6 |
hpr strains | 6 |
protease inhibitors | 6 |
immune recognition | 6 |
healthcare workers | 6 |
sequence carries | 6 |
herpes simplex | 6 |
interferon signaling | 6 |
studies using | 6 |
virus surveillance | 6 |
protein complex | 6 |
minor allele | 6 |
mean number | 6 |
infected mice | 6 |
transcription complex | 6 |
high viral | 6 |
virus assembly | 6 |
negative regulator | 6 |
hemagglutinin esterase | 6 |
vivo properties | 6 |
showed increased | 6 |
side effects | 6 |
free water | 6 |
protease activity | 6 |
vector vaccine | 6 |
protein interaction | 6 |
major histocompatibility | 6 |
human patients | 6 |
domestic pigs | 6 |
premature stop | 6 |
diagnostic laboratory | 6 |
fluorescent antibody | 6 |
virus neutralization | 6 |
proteolytic cleavage | 6 |
start site | 6 |
human disease | 6 |
gene sequences | 6 |
acute lung | 6 |
livestock viruses | 6 |
phylogenetic tree | 6 |
virus hemagglutinin | 6 |
health implications | 6 |
significant difference | 6 |
antiviral molecules | 6 |
east africa | 6 |
central nervous | 6 |
investigation reported | 6 |
copies per | 6 |
lassa fever | 6 |
cytokine production | 6 |
surface glycoprotein | 6 |
th day | 6 |
may help | 6 |
one cat | 6 |
infect humans | 6 |
protein inhibits | 6 |
virus isolate | 6 |
vector borne | 6 |
study also | 6 |
also identified | 6 |
different locations | 6 |
may enhance | 6 |
swine may | 6 |
key components | 6 |
strains used | 6 |
disease patients | 6 |
blood monocytes | 6 |
multiplex real | 6 |
comparative study | 6 |
protein level | 6 |
acid inducible | 6 |
chickens infected | 6 |
i pbm | 6 |
study conducted | 6 |
influenza infections | 6 |
virus leader | 6 |
antibody test | 6 |
possible correlation | 6 |
predictive value | 6 |
early transmission | 6 |
iav seroprevalence | 6 |
inactivated vaccines | 6 |
school children | 6 |
host genetic | 6 |
countries worldwide | 6 |
bootstrap phylogenetic | 6 |
viral vectors | 6 |
dna viruses | 6 |
different zoonotic | 6 |
infection control | 6 |
ha gene | 6 |
virus pathogenesis | 6 |
akt pathway | 6 |
outbreak associated | 6 |
cleavage sites | 6 |
elderly patients | 6 |
mouse lungs | 6 |
control programs | 6 |
immunoinformatic approach | 6 |
modifying enzymes | 6 |
sars virus | 6 |
mixing vessel | 6 |
allow us | 6 |
essential role | 6 |
melanoma differentiation | 6 |
naturally occurring | 6 |
pathogen recognition | 6 |
evolutionary history | 6 |
infected cattle | 6 |
virus ns | 6 |
lamina propria | 6 |
vaccine strain | 6 |
aedes aegypti | 6 |
chicken eggs | 6 |
protein database | 6 |
suis clinical | 6 |
protective immunity | 6 |
suppressor protein | 6 |
human adenovirus | 6 |
active surveillance | 6 |
different regions | 6 |
nursery piglets | 6 |
serological investigations | 6 |
license key | 6 |
specific primers | 6 |
cell type | 6 |
positive correlation | 6 |
via direct | 6 |
fusion proteins | 6 |
transmission involving | 6 |
start sites | 6 |
membrane vesicles | 6 |
vp inhibits | 6 |
pathogenic bacteria | 6 |
histocompatibility complex | 6 |
pigs infected | 6 |
mice infected | 6 |
test results | 6 |
antimicrobial use | 6 |
furin cleavage | 6 |
biology approaches | 6 |
probable bat | 6 |
resistance genes | 6 |
quantitative reverse | 6 |
infected people | 6 |
contact animals | 6 |
ethics committee | 6 |
international workshop | 6 |
virus challenge | 6 |
respiratory failure | 6 |
nk cells | 6 |
sf cells | 6 |
wild boar | 6 |
clinical strains | 6 |
like strains | 6 |
isg expression | 6 |
two animals | 6 |
low virulence | 6 |
novel swine | 6 |
fluid samples | 6 |
host defense | 6 |
innate antiviral | 6 |
na subtypes | 6 |
severe symptoms | 6 |
ifn antagonists | 6 |
ndv strains | 6 |
febrile illness | 6 |
antigenic diversity | 6 |
assisted isolation | 6 |
bisphosphate aldolase | 6 |
pcr amplification | 6 |
positively correlated | 6 |
genome copies | 6 |
least two | 6 |
clinical course | 6 |
stock viruses | 6 |
total number | 6 |
multiple reports | 6 |
transmissible gastroenteritis | 6 |
similar results | 6 |
considered negative | 6 |
like promoters | 6 |
among children | 6 |
intensive care | 6 |
gondii activity | 6 |
virus studies | 6 |
gene source | 6 |
lassa virus | 6 |
infected co | 6 |
associated molecular | 6 |
results suggest | 6 |
waterborne outbreaks | 6 |
suis strain | 6 |
transmembrane domain | 6 |
per sites | 6 |
intensity shedders | 6 |
chpv strain | 6 |
common cold | 6 |
vaccine candidate | 6 |
primarily epithelial | 6 |
one sample | 6 |
coding regions | 6 |
saffold virus | 6 |
fcov antigen | 6 |
idv sequences | 6 |
triple reassortant | 6 |
new regulation | 6 |
regulatory networks | 6 |
natural host | 6 |
influenza research | 6 |
recent developments | 6 |
pcr test | 6 |
reassortant iav | 6 |
bird markets | 6 |
data indicate | 6 |
groups treated | 6 |
infected calves | 6 |
ns proteins | 6 |
serum sample | 6 |
distinct viruses | 6 |
rvf virus | 6 |
tax protein | 6 |
transmembrane serine | 6 |
different countries | 6 |
preferentially targets | 6 |
washed three | 6 |
strain vaccine | 6 |
like virus | 6 |
tax oncoprotein | 6 |
protein function | 6 |
bovine serum | 6 |
iii interferon | 6 |
capsular polysaccharide | 6 |
highly susceptible | 6 |
cervical cancer | 6 |
horizontal transmission | 5 |
preliminary report | 5 |
coronavirus nonstructural | 5 |
clinical findings | 5 |
viral binding | 5 |
will also | 5 |
environmental factors | 5 |
recently reported | 5 |
arabia middle | 5 |
swiss roll | 5 |
mucosal immunity | 5 |
single amino | 5 |
percentile rank | 5 |
reunion island | 5 |
primary human | 5 |
bird species | 5 |
ligand binding | 5 |
bacterial species | 5 |
rna helicase | 5 |
geographical distribution | 5 |
domain protein | 5 |
interferon response | 5 |
genes associated | 5 |
receptor specificity | 5 |
existing drugs | 5 |
based methods | 5 |
protective efficacy | 5 |
promoter regions | 5 |
gov blast | 5 |
ebola outbreak | 5 |
model systems | 5 |
human subjects | 5 |
health problem | 5 |
first cases | 5 |
reading frames | 5 |
data repository | 5 |
human beta | 5 |
related calcium | 5 |
lateral flow | 5 |
sample size | 5 |
factor kappa | 5 |
induce apoptosis | 5 |
conserved sequences | 5 |
chinese patients | 5 |
one organ | 5 |
cell membranes | 5 |
wnv antibodies | 5 |
order nidovirales | 5 |
disease complex | 5 |
transforming growth | 5 |
killed approximately | 5 |
infected cases | 5 |
wild ducks | 5 |
environmental water | 5 |
results consistent | 5 |
present work | 5 |
small ruminants | 5 |
genome type | 5 |
dna vaccine | 5 |
active chromatin | 5 |
virus specific | 5 |
three fecal | 5 |
zu tissue | 5 |
provided evidence | 5 |
pig viruses | 5 |
endou activity | 5 |
intervention strategies | 5 |
viral zoonoses | 5 |
research articles | 5 |
us swine | 5 |
enteric disorders | 5 |
sars convalescents | 5 |
chromatin status | 5 |
large numbers | 5 |
synergic compound | 5 |
secondary infection | 5 |
virus binding | 5 |
dna sequence | 5 |
soluble resistance | 5 |
recombination site | 5 |
heparan sulfate | 5 |
pneumonia cases | 5 |
antimicrobial resistant | 5 |
pseudomonas aeruginosa | 5 |
vital role | 5 |
csfv rna | 5 |
may involve | 5 |
significant reduction | 5 |
new jersey | 5 |
coronavirus using | 5 |
respiratory epithelial | 5 |
i mda | 5 |
recombination events | 5 |
natural killer | 5 |
reported globally | 5 |
transgenic mice | 5 |
severe pneumonia | 5 |
signal transducer | 5 |
phase i | 5 |
porcine intestinal | 5 |
transient expression | 5 |
type viruses | 5 |
geographic distribution | 5 |
may affect | 5 |
antiviral defense | 5 |
buffalo pox | 5 |
microbial communities | 5 |
gene locus | 5 |
virus detection | 5 |
selected immunogenic | 5 |
sampling period | 5 |
sigmodon hispidus | 5 |
receptor ace | 5 |
antagonistic mechanisms | 5 |
data integration | 5 |
strain vr | 5 |
show high | 5 |
vbnc cells | 5 |
encephalomyocarditis virus | 5 |
pcr reactions | 5 |
recombinant protein | 5 |
quality control | 5 |
vaccination protocols | 5 |
rectal swabs | 5 |
systems may | 5 |
recombinant newcastle | 5 |
genome analysis | 5 |
irf phosphorylation | 5 |
analysis revealed | 5 |
acid receptors | 5 |
significantly greater | 5 |
higher mutation | 5 |
downstream signaling | 5 |
study protocol | 5 |
mutation frequency | 5 |
giardia intestinalis | 5 |
weak rt | 5 |
viruses detected | 5 |
vesicular stomatitis | 5 |
transmembrane protease | 5 |
expression system | 5 |
nested pcr | 5 |
hajj pilgrimage | 5 |
pcr detection | 5 |
circulatory systems | 5 |
epidemic diarrhoea | 5 |
different conditions | 5 |
relatively low | 5 |
authors noted | 5 |
economic impact | 5 |
protease cleavage | 5 |
protective immune | 5 |
commonly recognized | 5 |
among patients | 5 |
related viruses | 5 |
akt signalling | 5 |
qmra approach | 5 |
hajj season | 5 |
study period | 5 |
certain ibv | 5 |
murine coronavirus | 5 |
visa protein | 5 |
purified using | 5 |
transmission success | 5 |
high intensity | 5 |
suis meningitis | 5 |
proteasomal degradation | 5 |
infiltrative viruses | 5 |
two weeks | 5 |
potential novel | 5 |
throughput technologies | 5 |
conformational change | 5 |
culture supernatants | 5 |
geographical area | 5 |
different mechanisms | 5 |
healthy controls | 5 |
therapeutic strategies | 5 |
three infiltration | 5 |
gross lesions | 5 |
oligoryzomys flavescens | 5 |
oxidoreductase map | 5 |
australian clones | 5 |
lower adherence | 5 |
postmortem examination | 5 |
total nucleic | 5 |
swine flu | 5 |
na gene | 5 |
pdz substrates | 5 |
migratory bird | 5 |
newly recognized | 5 |
risk allele | 5 |
protein interactions | 5 |
genetic drift | 5 |
different ages | 5 |
multiple viruses | 5 |
spearman correlation | 5 |
virus vector | 5 |
data types | 5 |
fusion domain | 5 |
ten days | 5 |
swine iav | 5 |
high antibody | 5 |
west africa | 5 |
promote viral | 5 |
reactive oxygen | 5 |
following infection | 5 |
antimicrobial usage | 5 |
dna polymerase | 5 |
studies suggest | 5 |
high levels | 5 |
ii pneumocytes | 5 |
viral genomic | 5 |
negative fecal | 5 |
sample collection | 5 |
global concern | 5 |
staphylococcus aureus | 5 |
arab emirates | 5 |
new insights | 5 |
viruses tend | 5 |
rodent populations | 5 |
first outbreak | 5 |
avian strains | 5 |
isav infection | 5 |
parasitic effect | 5 |
health authorities | 5 |
adenovirus type | 5 |
cause mild | 5 |
epidemiological situation | 5 |
kidney disease | 5 |
virus induces | 5 |
cryptosporidium infection | 5 |
lung cells | 5 |
near future | 5 |
specific gene | 5 |
ruffled feathers | 5 |
two groups | 5 |
viral surface | 5 |
clinical outcomes | 5 |
mortality rates | 5 |
may explain | 5 |
bluetongue virus | 5 |
absolutely diagnostic | 5 |
two viruses | 5 |
enteric disease | 5 |
emerging viral | 5 |
mechanisms underlying | 5 |
san diego | 5 |
oral route | 5 |
mers patients | 5 |
pathogen detection | 5 |
extracellular traps | 5 |
important antimicrobials | 5 |
related genes | 5 |
two distinct | 5 |
samples obtained | 5 |
may include | 5 |
gradually decreased | 5 |
splice site | 5 |
dhf virus | 5 |
nipah virus | 5 |
real time | 5 |
cell transmission | 5 |
virus structural | 5 |
fcov infected | 5 |
significant changes | 5 |
expression level | 5 |
integration approach | 5 |
results show | 5 |
membrane protein | 5 |
encoded proteins | 5 |
induced activation | 5 |
highly expressed | 5 |
relative humidity | 5 |
negative control | 5 |
viruses influenza | 5 |
harderian gland | 5 |
swine interaction | 5 |
cpg islands | 5 |
coding rnas | 5 |
animals also | 5 |
hla class | 5 |
evidence suggests | 5 |
families may | 5 |
novel cov | 5 |
four rt | 5 |
oxygen species | 5 |
long structural | 5 |
virus non | 5 |
rabies cases | 5 |
virus sequences | 5 |
antiviral state | 5 |
methylation status | 5 |
old female | 5 |
human macrophages | 5 |
destroying activities | 5 |
pasteurella multocida | 5 |
covs nsp | 5 |
unknown whether | 5 |
urgently needed | 5 |
scientific community | 5 |
recent common | 5 |
appendix i | 5 |
expression changes | 5 |
inhibits host | 5 |
bronchial epithelial | 5 |
distributed across | 5 |
german catteries | 5 |
fatal cases | 5 |
gondii antibodies | 5 |
cell cultures | 5 |
based detection | 5 |
health threat | 5 |
cysteine protease | 5 |
influenza outbreak | 5 |
sequence types | 5 |
phayao province | 5 |
research received | 5 |
regulatory factors | 5 |
virus origins | 5 |
terminal amino | 5 |
molecular biology | 5 |
junction proteins | 5 |
applied biosystems | 5 |
mediterranean basin | 5 |
recent reports | 5 |
novel anti | 5 |
mediated innate | 5 |
following experimental | 5 |
water buffaloes | 5 |
human keratinocytes | 5 |
stray dogs | 5 |
full ha | 5 |
gastroenteritis virus | 5 |
virus particles | 5 |
likelihood ratios | 5 |
clinical setting | 5 |
regulatory genomic | 5 |
human populations | 5 |
data available | 5 |
subcellular localization | 5 |
statistical significance | 5 |
mini kit | 5 |
epithelial transmission | 5 |
rna extraction | 5 |
bubalus bubalis | 5 |
utmost importance | 5 |
olfactory dysfunction | 5 |
end sites | 5 |
spillover events | 5 |
persistent infection | 5 |
antiviral genes | 5 |
uncharacterized oxidoreductase | 5 |
consistently detected | 5 |
genetic variants | 5 |
ns gene | 5 |
neutrophil extracellular | 5 |
disease burden | 5 |
acute infection | 5 |
many cases | 5 |
well known | 5 |
species including | 5 |
waterborne disease | 5 |
buffalo calves | 5 |
tract macrophages | 5 |
persistent viruses | 5 |
receptor usage | 5 |
novel virus | 5 |
red dot | 5 |
water sources | 5 |
fecal shedding | 5 |
day pi | 5 |
mediated degradation | 5 |
per gram | 5 |
person transmission | 5 |
zoonotic parasitosis | 5 |
population dynamics | 5 |
swine origin | 5 |
protease cleaves | 5 |
times higher | 5 |
pandemic viruses | 5 |
tbk ikk | 5 |
infection process | 5 |
interferon pathway | 5 |
intestinal translocation | 5 |
epidemiological study | 5 |
avian viruses | 5 |
giardia lamblia | 5 |
range genes | 5 |
molecular patterns | 5 |
first isolation | 5 |
ten years | 5 |
fcov strain | 5 |
peromyscus maniculatus | 5 |
northern egypt | 5 |
transmission among | 5 |
peromyscus leucopus | 5 |
protein binds | 5 |
raw milk | 5 |
clotting cascade | 5 |
human pathogens | 5 |
found seropositive | 5 |
cellular entry | 5 |
european union | 5 |
human schistosomiasis | 5 |
promotes virus | 5 |
multiple functions | 5 |
iav disease | 5 |
chemokine receptor | 5 |
sequences identified | 5 |
molecular level | 5 |
distribution system | 5 |
capture elisa | 5 |
highly attenuated | 5 |
among others | 5 |
nasopharyngeal swab | 5 |
immune suppression | 5 |
may cause | 5 |
maximum likelihood | 5 |
zika virus | 5 |
first identified | 5 |
human diseases | 5 |
different types | 5 |
genomic clusters | 5 |
gene regulatory | 5 |
strain trangie | 5 |
united arab | 5 |
important zoonotic | 5 |
significant increase | 5 |
sequence data | 5 |
cell adhesion | 5 |
isav fusion | 5 |
pathogenic pathotype | 5 |
studies showed | 5 |
initiation factors | 5 |
protein ega | 5 |
without fip | 5 |
associated protein | 5 |
pathological manifestations | 5 |
experimental conditions | 5 |
histone mimicry | 5 |
angiotensin ii | 5 |
will allow | 5 |
clustered together | 5 |
pedv replication | 5 |
cats infected | 5 |
water samples | 5 |
virus development | 5 |
comparative studies | 5 |
putative receptor | 5 |
infected animal | 5 |
viral spike | 5 |
may induce | 5 |
bola haplotypes | 5 |
york city | 5 |
eukaryotic initiation | 5 |
human strain | 5 |
genome contains | 5 |
identify regulatory | 5 |
specific vaccine | 5 |
granulomatous lesions | 5 |
american swine | 5 |
induces apoptosis | 5 |
malate dehydrogenase | 5 |
expression vector | 5 |
disease outcome | 5 |
tyrosine phosphatase | 5 |
specific monoclonal | 5 |
emerging pathogen | 5 |
author contributions | 5 |
also induces | 5 |
intestinal colonisation | 5 |
slicing sites | 5 |
encephalitis virus | 5 |
factors involved | 5 |
lb pro | 5 |
animal bites | 5 |
regulatory circuit | 5 |
various cytokines | 5 |
transmembrane protein | 5 |
external funding | 5 |
income countries | 5 |
potential use | 5 |
sensitive detection | 5 |
analysis showed | 5 |
important host | 5 |
following emerging | 5 |
different pathogens | 5 |
cats experimentally | 5 |
largely unknown | 5 |
chicken flocks | 5 |
inflammatory cells | 5 |
based vaccines | 5 |
infection risk | 5 |
pcr products | 5 |
transcriptional end | 5 |
infiltration ranking | 5 |
acid binding | 5 |
bovine respiratory | 5 |
several viruses | 5 |
recent findings | 5 |
vp interacts | 5 |
computed tomography | 5 |
new world | 5 |
fipv pathotype | 5 |
ifn regulatory | 5 |
bpxv infections | 5 |
ciliated cells | 5 |
reservoir host | 5 |
lesions potentially | 5 |
positive cervical | 4 |
recombinant fmdv | 4 |
protein syntenin | 4 |
birds showed | 4 |
serine threonine | 4 |
active transcription | 4 |
peruvian isolate | 4 |
dna microarrays | 4 |
many studies | 4 |
recent data | 4 |
influenza severity | 4 |
orfs abc | 4 |
mosquito vectors | 4 |
serological procedures | 4 |
avian virus | 4 |
sequences obtained | 4 |
just internal | 4 |
jak protein | 4 |
regulatory framework | 4 |
severe infections | 4 |
investigation identified | 4 |
active infections | 4 |
three swine | 4 |
virus remains | 4 |
related coronaviruses | 4 |
per year | 4 |
identify modifications | 4 |
antigen capture | 4 |
fatal human | 4 |
also possible | 4 |
virus molecular | 4 |
control epigenetic | 4 |
associated gene | 4 |
crosslinked chromatin | 4 |
detection method | 4 |
risk group | 4 |
extracted using | 4 |
natural transmission | 4 |
clinical samples | 4 |
bat sars | 4 |
clinical data | 4 |
animal reservoir | 4 |
potential anti | 4 |
backyard birds | 4 |
antiviral signaling | 4 |
evaluated using | 4 |
smallpox vaccines | 4 |
recent investigation | 4 |
like dnmts | 4 |
community transmission | 4 |
first active | 4 |
virus expressing | 4 |
iav subtype | 4 |
immunoproteomic approach | 4 |
involving internal | 4 |
bovine pestivirus | 4 |
dead swine | 4 |
disease outcomes | 4 |
novel strain | 4 |
titers also | 4 |
six samples | 4 |
shed virus | 4 |
pulmonary disease | 4 |
spectrum beta | 4 |
emerging infectious | 4 |
stranded positive | 4 |
lipid metabolism | 4 |
schistosoma haematobium | 4 |
severe complications | 4 |
obtaining covid | 4 |
reactive protein | 4 |
neglected american | 4 |
stress response | 4 |
symptom onset | 4 |
rectal temperature | 4 |
virus protein | 4 |
wuhan wet | 4 |
sperm production | 4 |
ibv variants | 4 |
stress granule | 4 |
control study | 4 |
finding suggests | 4 |
recombinant ace | 4 |
body fluids | 4 |
bootstrap replicates | 4 |
fcov shedders | 4 |
inflammatory syndrome | 4 |
protein translation | 4 |
viral deubiquitinase | 4 |
protein suppresses | 4 |
actively regulate | 4 |
young children | 4 |
cellular membranes | 4 |
severe illness | 4 |
alkhurma virus | 4 |
vascular leakage | 4 |
mechanisms involved | 4 |
genetic factors | 4 |
tested negative | 4 |
initial infection | 4 |
mediated activation | 4 |
four animals | 4 |
available information | 4 |
degradation via | 4 |
national health | 4 |
target cell | 4 |
envelope proteins | 4 |
china isolation | 4 |
controlled trial | 4 |
several reports | 4 |
hpr length | 4 |
large scale | 4 |
subclinical stage | 4 |
common practice | 4 |
functional analysis | 4 |
fmdv genome | 4 |
highest prevalence | 4 |
therapeutic target | 4 |
histone tail | 4 |
disease may | 4 |
domestic poultry | 4 |
signaling adapter | 4 |
cov resulted | 4 |
human exposure | 4 |
mainland china | 4 |
growing body | 4 |
pathotype fcovs | 4 |
considered primarily | 4 |
kinase activation | 4 |
tank binding | 4 |
dakahlia governorate | 4 |
summer months | 4 |
expression profile | 4 |
domestic cats | 4 |
north africa | 4 |
horseshoe bats | 4 |
bpxv strains | 4 |
report showed | 4 |
nigerian swine | 4 |
coronavirus type | 4 |
highly polymorphic | 4 |
magnetic resonance | 4 |
mentioned previously | 4 |
eukaryote chromatin | 4 |
current state | 4 |
important issues | 4 |
prefusion conformation | 4 |
ncov spike | 4 |
npcr results | 4 |
protein fusion | 4 |
i fusion | 4 |
encodes several | 4 |
nsp exon | 4 |
ct value | 4 |
proteins may | 4 |
circulating strains | 4 |
isolate regulatory | 4 |
marks across | 4 |
might also | 4 |
multiplex rt | 4 |
mononuclear cell | 4 |
blood cultures | 4 |
infected host | 4 |
generated using | 4 |
histone mark | 4 |
increased occupancy | 4 |
coronavirus middle | 4 |
mycobacterium bovis | 4 |
health significance | 4 |
coronavirus pathogenesis | 4 |
makkah city | 4 |
canadian swine | 4 |
restriction enzymes | 4 |
iav isolates | 4 |
receptor signaling | 4 |
sick swine | 4 |
individual viruses | 4 |
standard deviation | 4 |
adaptive immunity | 4 |
different fcov | 4 |
data collection | 4 |
induced signaling | 4 |
bursal disease | 4 |
discussion section | 4 |
suis associated | 4 |
contaminated food | 4 |
infection group | 4 |
obtained using | 4 |
sequence type | 4 |
four swine | 4 |
serosal surfaces | 4 |
exclusively found | 4 |
later stages | 4 |
acute kidney | 4 |
prostate cancer | 4 |
schistosoma mansoni | 4 |
australian isolates | 4 |
specific sites | 4 |
adverse effects | 4 |
across different | 4 |
culture cells | 4 |
binding motifs | 4 |
high dose | 4 |
sequences reported | 4 |
dependent neuroprotective | 4 |
factor alpha | 4 |
recovered patients | 4 |
pig population | 4 |
influenza vaccines | 4 |
selected epitopes | 4 |
kidney injury | 4 |
significant public | 4 |
receptor subunit | 4 |
endemic areas | 4 |
suis taken | 4 |
rice rat | 4 |
olfactory evaluation | 4 |
epidemiological unit | 4 |
treatment options | 4 |
ismailia governorate | 4 |
cl pro | 4 |
interferon responses | 4 |
will help | 4 |
host relationships | 4 |
positive controls | 4 |
multiple hosts | 4 |
exoribonuclease activity | 4 |
five strains | 4 |
pathogen free | 4 |
bovine coronavirus | 4 |
faire method | 4 |
body viruses | 4 |
nuclear magnetic | 4 |
neuroprotective protein | 4 |
may interfere | 4 |
culture supernatant | 4 |
linear epitopes | 4 |
multiple serotypes | 4 |
result shows | 4 |
serotype switch | 4 |
hpv types | 4 |
showed higher | 4 |
modifier molecules | 4 |
clade represents | 4 |
receptor genes | 4 |
using comparative | 4 |
high proportion | 4 |
different tissues | 4 |
cytopathic effect | 4 |
old man | 4 |
ros activity | 4 |
primers used | 4 |
via infected | 4 |
lysosomal degradation | 4 |
interferon antagonism | 4 |
culture system | 4 |
partial vp | 4 |
live animals | 4 |
cases worldwide | 4 |
maya people | 4 |
higher expression | 4 |
driven plasmids | 4 |
severe course | 4 |
infection may | 4 |
well established | 4 |
lysis via | 4 |
cultured cells | 4 |
dry cough | 4 |
nucleotide sequence | 4 |
soluble ace | 4 |
housekeeping gene | 4 |
cellular tropism | 4 |
gondii effects | 4 |
also present | 4 |
modifications genome | 4 |
common among | 4 |
human homologue | 4 |
prevalence rate | 4 |
methionine residue | 4 |
dna replication | 4 |
occupational exposure | 4 |
tertiary structure | 4 |
transcriptional response | 4 |
aa similarity | 4 |
respiratory infections | 4 |
parasitic diseases | 4 |
highly sensitive | 4 |
vaccine candidates | 4 |
cloacal pasting | 4 |
fully understood | 4 |
inactivated autogenous | 4 |
new cov | 4 |
previously unknown | 4 |
cc genotype | 4 |
orf pbm | 4 |
virus vaccines | 4 |
group tested | 4 |
antiviral effects | 4 |
remains unclear | 4 |
intestinal loops | 4 |
load per | 4 |
viral mrnas | 4 |
cecal tonsils | 4 |
extracellular vesicles | 4 |
data showed | 4 |
specific isg | 4 |
virus propagation | 4 |
patients died | 4 |
hcovs infections | 4 |
may trigger | 4 |
antibodies among | 4 |
coronavirus rna | 4 |
cell epitope | 4 |
transcriptional start | 4 |
specific receptor | 4 |
south korean | 4 |
swine viruses | 4 |
cell contacts | 4 |
prospective cohort | 4 |
three colonies | 4 |
entry factors | 4 |
vertical transmission | 4 |
th international | 4 |
stomatitis virus | 4 |
expression profiles | 4 |
major role | 4 |
transcription loop | 4 |
environmental samples | 4 |
primarily involving | 4 |
induced lung | 4 |
another investigation | 4 |
genetic reassortment | 4 |
virus cell | 4 |
salmonella isolates | 4 |
saudi population | 4 |
virus diversity | 4 |
receptor destruction | 4 |
sense copy | 4 |
card domains | 4 |
intranasal inoculation | 4 |
involves crosslinking | 4 |
fully functional | 4 |
human virus | 4 |
high number | 4 |
takes place | 4 |
method used | 4 |
pol ii | 4 |
pig sera | 4 |
associated substrate | 4 |
cps locus | 4 |
virus transmitted | 4 |
suis st | 4 |
histone modifier | 4 |
certain strains | 4 |
membrane proteins | 4 |
old saudi | 4 |
high morbidity | 4 |
pbs washes | 4 |
positive children | 4 |
viral sepsis | 4 |
within europe | 4 |
derived antibodies | 4 |
research database | 4 |
molecular diagnostics | 4 |
case definition | 4 |
infectious ndv | 4 |
evolutionary genetics | 4 |
nonclinical strains | 4 |
veterinary medicine | 4 |
predictive values | 4 |
ibv serotypes | 4 |
virus antibody | 4 |
mediated ifn | 4 |
showed lesions | 4 |
strain fcov | 4 |
negative controls | 4 |
buenos aires | 4 |
suis vaccines | 4 |
controlling chromatin | 4 |
combination therapy | 4 |
oklahoma based | 4 |
treatment plants | 4 |
therapeutic targets | 4 |
targets heavily | 4 |
fmdv proteins | 4 |
three plasmids | 4 |
egyptian governorates | 4 |
studies used | 4 |
cytokine response | 4 |
cytokine signaling | 4 |
case reports | 4 |
strongly inhibits | 4 |
causing viruses | 4 |
mucosal surfaces | 4 |
novel human | 4 |
previous data | 4 |
new mechanism | 4 |
specific cd | 4 |
airway epithelia | 4 |
review focuses | 4 |
epithelial viruses | 4 |
directly related | 4 |
five cats | 4 |
salmon rbcs | 4 |
coding sequence | 4 |
factors affecting | 4 |
coronavirus genome | 4 |
vivo infection | 4 |
haemophilus parasuis | 4 |
reservoir hosts | 4 |
taking advantage | 4 |
protein identifiers | 4 |
membrane glycoprotein | 4 |
mouse lung | 4 |
among multiple | 4 |
eif gi | 4 |
global distribution | 4 |
sybr green | 4 |
central america | 4 |
three main | 4 |
microbes infect | 4 |
vp tree | 4 |
host species | 4 |
factor beta | 4 |
get infected | 4 |
viral structure | 4 |
without showing | 4 |
low concentrations | 4 |
longitudinal study | 4 |
interstitial pneumonia | 4 |